'Positive predictive value' diaporamas de présentation

Week 7 USMLE Step 1 Review: Biostatistics, Behavioral Science, and Nutrition

Steven Katz MSIV. Week 7 USMLE Step 1 Review: Biostatistics, Behavioral Science, and Nutrition. PART 1: BIOSTATISTICS. Terms:

1.72k views • 90 slides

Ovarian Cancer

Ovarian Cancer. Annette Chen, MD Division Gynecologic Oncology UMass Memorial Medical Center. The Case of Olivia Carson. You are a generalist in the community. You have a new patient. She is a 65 year old with a large pelvic mass arising from the right adnexum. The Case of Olivia Carson.

1.21k views • 71 slides

Prof. Fatma M. Nasrat Prof. Of Clinical Immunology Department of Clinical Pathology National Cancer Institute Cairo / Eg

Monitoring colorectal Cancer after resection Relationship to operative curability. Prof. Fatma M. Nasrat Prof. Of Clinical Immunology Department of Clinical Pathology National Cancer Institute Cairo / Egypt. Follow-up after management of colon cancer with curative intent.

749 views • 42 slides

From the analytical uncertainty to uncertainty in data interpretation D. Concordet, J.P. Braun d.concordet@envt.fr

From the analytical uncertainty to uncertainty in data interpretation D. Concordet, J.P. Braun d.concordet@envt.fr jp.braun@envt.fr . Biological - species - status (healthy, sick) - breed - format, age... - inter-individual - intra-individual Metrological

456 views • 34 slides

517 views • 34 slides

Case-Control Study Design

Case-Control Study Design. Two groups are selected, one of people with the disease ( cases ), and the other of people with the same general characteristics but without the disease ( controls ) Compare the past exposures of both groups. Case Control Study Design. Exposed. Diseased (Cases).

2.45k views • 29 slides

Critical appraisal of a diagnostic paper

445 views • 28 slides

AMOS Health & Hope: NICARAGUA

AMOS Health & Hope: NICARAGUA. Sarah Paraghamian, MS2 Summer 2011. Community Based Primary Health Care. Responsive to needs Participatory Quality-oriented S cientifically sound Accountable Intersectoral. Where AMOS Works. My Project.

394 views • 27 slides

TESTING A TEST

TESTING A TEST. Ian McDowell Department of Epidemiology & Community Medicine January 2008. The Challenge of Clinical Measurement. Diagnoses are based on information, from formal measurements and/or from your clinical judgment This information is seldom perfectly accurate:

379 views • 25 slides

Mei Baker, M.D., FACMG Associate Professor, Department of Pediatrics

Universal Newborn Screening for Severe Combined Immunodeficiency APHL/CDC Newborn Screening Molecular Workshop Atlanta, GA July 9, 2012. Mei Baker, M.D., FACMG Associate Professor, Department of Pediatrics Co-Director, NBS Laboratory at WSLH

461 views • 25 slides

Probability

888 views • 24 slides

Diagnostic Test Characteristics

Diagnostic Test Characteristics. Professor Mobeen Iqbal Shifa College of Medicine. Case.

390 views • 21 slides

POSITIVE PREDICTIVE VALUE OF AHRQ PATIENT SAFETY INDICATORS IN A NATIONAL SAMPLE OF HOSPITALS

POSITIVE PREDICTIVE VALUE OF AHRQ PATIENT SAFETY INDICATORS IN A NATIONAL SAMPLE OF HOSPITALS. AcademyHealth Annual Research Meeting June 9, 2008 Team presenter: Pat Zrelak PhD, CNRN, CNAA-BC 1 Team: Patrick Romano 1 ; Garth Utter 1 ; Richard White 1 ; Dan Tancredi 1 ;

334 views • 19 slides

Screening

Screening. Phil Thirkell. What is screening?. A process of identifying apparently healthy people who may be at risk of a disease or condition Identify Apparently healthy Increased risk of a disease/condition. Give 4 screening programmes undertaken in the UK. Antenatal screening

473 views • 19 slides

Practical application

Practical application . Population A.

245 views • 14 slides

Monitoring HIV tropism and Maraviroc regimens in clinical routine - 24 weeks of follow-up data -

Monitoring HIV tropism and Maraviroc regimens in clinical routine - 24 weeks of follow-up data -. Heribert Knechten, MD PZB Aachen, Germany. T = 5. Abstract No.: TUPDB202. Monitoring HIV tropism and Maraviroc regimens in clinical routine - 24 weeks of follow-up data -. N = 51

150 views • 5 slides